CDCap™ EBV Panel is hybridization capture-based target enrichment solution for Next Generation Sequencing (NGS) on Illumina and MGI sequencing platforms.It enables research on Epstein-Barr virus (EBV)-related cancers, including nasopharyngeal carcinoma, lymphoma, and gastric cancer.
comprehensive genome design
· designed based on the full-length sequences of 304 EBV genomes
sample compatibility
· compatible with various sample types including tissue, cells, and plasma
platform flexibility
· compatible with both Illumina and MGI sequencing platforms
analysis capabilities
· enables EBV typing, mutation detection, and virus-host genomic integration site analysis
| Enrichment Method: | Probe Hybridization Capture |
| Species: | viruses |
| Target Size: | 52.4 Mb |
| Pathogen Type: | EBV,306 full-length sequence of EBV |
| Sample Type: | tissue, cells, and plasma etc. |
| Method: | NGS |
| Sequencing Platform: | Illumina |
| Storage: | Store at -20 °C. |
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.
Please fill out the form below: ×
